Bristol-Myers Squibb gains 1.1% as the double bottom pushes the stock toward the reversal threshold

Bristol-Myers Squibb is in the sixteenth week of a sell signal, listed on the New York Stock Exchange. The week just closed gained 1.1%, the fourth straight week of technical improvement: the double bottom in the 54 area has already produced an 8% rebound, and the stock is again nearing the threshold that separates the decline from its exhaustion.